Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma
Rhabdomyosarcoma (RMS), a cancer characterized by features of skeletal muscle, is the most common soft‐tissue sarcoma of childhood. With 5‐year survival rates among high‐risk groups at < 30%, new therapeutics are desperately needed. Previously, using a myoblast‐based model of fusion‐negative RMS...
Main Authors: | Alexander R. Kovach, Kristianne M. Oristian, David G. Kirsch, Rex C. Bentley, Changde Cheng, Xiang Chen, Po‐Han Chen, Jen‐Tsan Ashley Chi, Corinne M. Linardic |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13304 |
Similar Items
-
PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis
by: Genevieve C Kendall, et al.
Published: (2018-06-01) -
Expression of cyclin-dependent kinase inhibitors (CDKN1, CDKN5) in developmentally competent and incompetent porcine oocytes
by: H. Piotrowska, et al.
Published: (2013-09-01) -
SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer
by: Shan-Yueh Chang, et al.
Published: (2023-04-01) -
Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension
by: Filiz Kisaayak Collak, et al.
Published: (2017-12-01) -
MAF1 represses CDKN1A through a Pol III-dependent mechanism
by: Yu-Ling Lee, et al.
Published: (2015-06-01)